MATA NATHAN L. (Chief Scientific Officer) sold 6.8% of their position (1K shares) of BELITE BIO, INC on the open market
Open‑market sale worth $161.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
American depositary share
Shares
−32.00
Price / share
$158.46
Trade value
$5.07K
% of position
American depositary share
Shares
−52.00
Price / share
$159.38
Trade value
$8.29K
% of position
American depositary share
Shares
−226.00
Price / share
$160.55
Trade value
$36.28K
% of position
American depositary share
Shares
−274.00
Price / share
$161.41
Trade value
$44.23K
% of position
American depositary share
Shares
−216.00
Price / share
$162.48
Trade value
$35.10K
% of position
American depositary share
Shares
−200.00
Price / share
$163.32
Trade value
$32.66K
% of position
Net shares
−1K
Net value
-$161.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American depositary share Direct | 4/17/2026 | S · Sale | −32.00 | $158.46 | $5.07K | 0.2% | 14.67K | 14.63K |
| American depositary share Direct | 4/17/2026 | S · Sale | −52.00 | $159.38 | $8.29K | 0.4% | 14.63K | 14.58K |
| American depositary share Direct | 4/17/2026 | S · Sale | −226.00 | $160.55 | $36.28K | 1.5% | 14.58K | 14.36K |
| American depositary share Direct | 4/17/2026 | S · Sale | −274.00 | $161.41 | $44.23K | 1.9% | 14.36K | 14.08K |
| American depositary share Direct | 4/17/2026 | S · Sale | −216.00 | $162.48 | $35.10K | 1.5% | 14.08K | 13.87K |
| American depositary share Direct | 4/17/2026 | S · Sale | −200.00 | $163.32 | $32.66K | 1.4% | 13.87K | 13.67K |
| Total | −1K | -$161.63K | ||||||